甲型ALD和ALD-区分这些影响管理和临床结果吗?
Fatima Elmustafa1, Mahima Tyagi1, Harpreet Kaur1
1Health and Jewish Hospital Transplant Hepatologist, University of Louisville School of Medicine, Physician University of Louisville Physicians Group, Hepatologist University of Louisville, Robley Rex VA Medical Center, Louisville, KY 40206, USA.
Current hepatology reports
|December 10, 2025
概括
代谢功能障碍和与酒精有关的肝病 (Met-ALD) 是一个新的临床实体. 它解决了代谢功能障碍和酒精使用的频繁共存,提供了新的研究和临床试验机会.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 内部医学 内部医学
- 胃肠病学 胃肠病学
背景情况:
- 术语非酒精性脂肪性肝病已经更新为与代谢功能障碍相关的脂肪性肝病 (MASLD).
- 一个新的实体,代谢功能障碍和与酒精有关的肝病 (Met-ALD) 已被引入.
- Met-ALD承认代谢功能障碍和酒精消费的频繁共存,这两者协同恶化肝损伤.
研究的目的:
- 深入研究Met-ALD风险分层,预后,自然史,药理管理和临床试验设计等方面的风险.
- 为Met-ALD.肝损伤的疾病和病变发生提供新的见解.
- 突出Met-ALD.的临床现实和影响.
主要方法:
- 文献综述和关于Met-ALD的当前知识的综合.
- 在Met-ALD.中分析由心脏代谢风险因素和酒精使用驱动的相互作用和途径.
- 讨论对患者分层,查和治疗策略的影响.
主要成果:
- 甲醇性肝病是一种独特的脂肪性肝病,具有重叠的MASLD和酒精相关肝病 (ALD) 的表型.
- 它填补了当前分类中的空白,认识到代谢功能障碍和酒精使用的频繁同时发生.
- 这种认可促进了准确的患者分层,提高了对双重风险因素的查,并定制了治疗策略.
结论:
- 引入Met-ALD带来了挑战,但也为研究和临床实践带来了重大机遇.
- 它对临床试验,流行病学研究和公共卫生计划有影响.
- 甲基ALD促进了更准确的理解和管理肝损伤的患者,有代谢功能障碍和酒精消费.
相关概念视频
Therapeutic Drug Monitoring: Affecting Factors
175
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
175
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
169
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169
Angina V: Nursing Management
277
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
277
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
192
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
192
Diabetes: Management and Pharmacotherapy
848
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
848
Myocarditis IV: Nursing Management
194
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
194
